Clinical Trials
| Cancer Type: Renal | |
| Description: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma | |
| Entity Approving The Trial: Eastern Cooperative Oncology Group (ECOG) |
|
| Phase: III | |
| Site-Wide Accrual Goal: 1,332 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| No related links found. |
 |
 |
|
